drugset / Trial / NCT01438918

X-Ray Study Investigating The Safety And Efficacy Of SD-6010 In Subjects With Osteoarthritis Of The Knee

NCT01438918 ↗

Phase 3 Withdrawn Pfizer
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this 2-year study is to evaluate the safety, tolerability and disease modifying efficacy of SD 6010, an inhibitor of inducible nitric oxide synthase (iNOS). The efficacy of SD-6010 will be evaluated by radiography using joint space narrowing in the medial tibiofemoral compartment of the study knee as the primary endpoint.

Timeline

Start
2012-03
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator SD-6010 Unknown 50 mg Oral
Comparator SD-6010 Unknown 200 mg Oral

Indications